The data presented here define that CCDC6, a partner of RET in papillary thyroid carcinoma and in lung adenocarcinoma, fine modulates the CREB1-dependent transcriptional activity through sumoylation both in vitro and in vivo. The gene discussed is CCDC6; the disease is lung adenocarcinoma.